ArticleFrontiers in immunology2024

Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody.

Anja Seckinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.